Radiation-Emitting Product Annual Reports and Accession Numbers: 2026 Deadlines
The meaning of the annual reporting cycle, the nodes submitted on 1 September and the numbering of the report, as explained by the FDA to 21 CFR 1002.13.
Reading Document Interpretation